{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakezor is indicated for the treatment of major depressive disorder in adults, generalized anxiety disorder, panic disorder, and social anxiety disorder. It is also indicated for the management of obsessive-compulsive disorder, post-traumatic stress disorder, and premenstrual dysphoric disorder. Additionally, Fakezor is recommended for the treatment of neuropathic pain and fibromyalgia in adults.\n\nList of indications:\n\n", "completion": "#major depressive disorder#\n#generalized anxiety disorder#\n#panic disorder#\n#social anxiety disorder#\n#obsessive-compulsive disorder#\n#post-traumatic stress disorder#\n#premenstrual dysphoric disorder#\n#neuropathic pain#\n#fibromyalgia#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakolizimab is indicated for the treatment of inflammatory bowel disease (Crohns disease and ulcerative colitis), rheumatoid arthritis, psoriasis, and ankylosing spondylitis in adult patients who have not responded adequately to conventional therapy. It is also indicated for the management of moderate to severe asthma in patients requiring additional therapy.\n\nList of indications:\n\n", "completion": "#inflammatory bowel disease (Crohns disease and ulcerative colitis)#\n#rheumatoid arthritis#\n#psoriasis#\n#ankylosing spondylitis#\n#moderate to severe asthma#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nIndications include the treatment of hypertension in adults with or without concomitant cardiovascular disease, prevention of cardiovascular events in patients with a history of myocardial infarction, and management of chronic stable angina in combination with other antianginal agents. It is also indicated for the treatment of heart failure in patients intolerant to ACE inhibitors, and for the management of chronic kidney disease in patients with diabetes.\n\nList of indications:\n\n", "completion": "#hypertension#\n#cardiovascular disease#\n#prevention of cardiovascular events#\n#myocardial infarction#\n#chronic stable angina#\n#heart failure#\n#ACE inhibitors#\n#chronic kidney disease#\n#diabetes#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakesyma is indicated for the treatment of hypertension in adult patients as monotherapy or in combination with other antihypertensive agents, such as diuretics or calcium channel blockers. Additionally, Fakesyma is also indicated for the management of type 2 diabetes mellitus in adults to improve glycemic control when diet and exercise alone do not provide adequate control.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nDrugX is indicated for the treatment of the following conditions:\n\n- Major Depressive Disorder in adults and adolescents aged 12 years and older\n- Generalized Anxiety Disorder in adults\n- Obsessive-Compulsive Disorder in pediatric patients aged 6 years and older\n- Panic Disorder with or without Agoraphobia in adults\n- Post-Traumatic Stress Disorder in adults and pediatric patients aged 6 years and older\n\nTreatment with DrugX should be initiated and monitored by a healthcare professional experienced in the management of psychiatric disorders.\n\nList of indications:\n\n", "completion": "#Major Depressive Disorder#\n#Generalized Anxiety Disorder#\n#Obsessive-Compulsive Disorder#\n#Panic Disorder#\n#Post-Traumatic Stress Disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of hypertension in adult patients, as well as for the management of mild to moderate depression in conjunction with psychotherapy. Additionally, Fauxzil is also indicated for the prevention of migraine headaches in patients with a history of recurrent migraines.\n\nList of indications:\n\n", "completion": "#hypertension#\n#mild to moderate depression#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of moderate to severe rheumatoid arthritis in adult patients who have not responded adequately to other disease-modifying antirheumatic drugs. It is also indicated for the management of chronic plaque psoriasis in patients with inadequate responses to conventional systemic therapies. Additionally, Fauxzil is indicated for the maintenance treatment of schizophrenia in adult patients to reduce the risk of relapse.\n\nList of indications:\n\n", "completion": "#rheumatoid arthritis#\n#chronic plaque psoriasis#\n#schizophrenia#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxivir is indicated for the treatment of rheumatoid arthritis in adult patients who have had an inadequate response to conventional therapy. Additionally, Fauxivir is also indicated for the management of moderate to severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy.\n\nList of indications:\n\n", "completion": "#rheumatoid arthritis#\n#moderate to severe plaque psoriasis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxdaxa is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled with monotherapy. It may be used alone or in combination with other antihypertensive agents.\n\nFauxdaxa is also indicated for the management of type 2 diabetes mellitus in adults to improve glycemic control when diet and exercise alone do not provide adequate control. This medication can be used as monotherapy or in combination with other oral antidiabetic agents or insulin.\n\nAdditionally, Fauxdaxa is indicated for the symptomatic treatment of moderate to severe generalized anxiety disorder in adults. It is recommended for use as part of a comprehensive treatment plan that includes psychological counseling and support.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#moderate to severe generalized anxiety disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nMythotrex is indicated for the treatment of rheumatoid arthritis in adult patients who have not responded adequately to conventional therapy. It is also indicated for the management of moderate to severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy. Additionally, Mythotrex is indicated for the treatment of active Crohns disease in adult patients who have not responded adequately to conventional therapies.\n\nList of indications:\n\n", "completion": "#rheumatoid arthritis#\n#plaque psoriasis#\n#Crohns disease#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications:\n5.1 Pharmacodynamic properties\n\nMechanism of action: \n\n[Synthovir] is a novel medication that acts as a selective serotonin reuptake inhibitor (SSRI) with additional agonistic activity at serotonin 5-HT1A receptors. The drug modulates serotonin levels in the central nervous system, leading to enhanced neurotransmission and regulation of mood. Furthermore, [Synthovir] exhibits affinity for alpha-1 adrenergic receptors, contributing to its anxiolytic effects.\n\nIndications:\n\n- Major Depressive Disorder: [Synthovir] is indicated for the treatment of major depressive disorder in adults, demonstrating efficacy in improving mood, reducing feelings of worthlessness, and restoring interest in daily activities.\n\n- Generalized Anxiety Disorder: [Synthovir] is approved for the management of generalized anxiety disorder in adults, alleviating symptoms of excessive worry, restlessness, and irritability.\n\n- Panic Disorder: [Synthovir] is indicated for the treatment of panic disorder with or without agoraphobia, effectively reducing the frequency and severity of panic attacks.\n\n- Social Anxiety Disorder: [Synthovir] is recommended for the management of social anxiety disorder, assisting patients in overcoming fear and avoidance of social situations.\n\n- Obsessive-Compulsive Disorder: [Synthovir] is prescribed for the treatment of obsessive-compulsive disorder, helping to reduce intrusive thoughts and compulsive behaviors.\n\n- Post-Traumatic Stress Disorder: [Synthovir] is indicated for post-traumatic stress disorder, alleviating symptoms such as flashbacks, hypervigilance, and nightmares.\n\n[Synthovir] offers a comprehensive approach to the treatment of various mood and anxiety disorders, providing relief to patients experiencing significant distress and impairment in daily functioning.\n\nList of indications:\n\n", "completion": "#Major Depressive Disorder#\n#Generalized Anxiety Disorder#\n#Panic Disorder#\n#Social Anxiety Disorder#\n#Obsessive-Compulsive Disorder#\n#Post-Traumatic Stress Disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakezor is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. It may be used alone or in combination with other antihypertensive agents such as diuretics.\n\nFakezor is also indicated for the management of chronic angina pectoris in adult patients. It can be used as monotherapy or in combination with other antianginal agents.\n\nIn addition, Fakezor is indicated for the prevention of migraine headaches in patients who experience frequent episodes. It is recommended for use as a prophylactic treatment to reduce the frequency and severity of migraine attacks.\n\nFurthermore, Fakezor may be prescribed for the management of neuropathic pain in diabetic patients who have not achieved adequate relief with other therapies. It can help alleviate the symptoms associated with diabetic neuropathy, improving patients quality of life.\n\nList of indications:\n\n", "completion": "#hypertension#\n#chronic angina pectoris#\n#migraine headaches#\n#neuropathic pain#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic indications**\n\n*Pseudotrex* is indicated for the treatment of:\n- Hypertension in adult patients with uncontrolled blood pressure\n- Type 2 diabetes mellitus with inadequate glycemic control\n- Rheumatoid arthritis in combination with methotrexate for patients who have not responded adequately to other treatments\n- Major depressive disorder in adults who have had an inadequate response to at least two antidepressants\n\nIt is important to note that *Pseudotrex* is not recommended for use in pregnant women or individuals with a history of hypersensitivity to any of the components of the product.\n\nList of indications:\n\n", "completion": "#Hypertension#\n#Type 2 diabetes mellitus#\n#Rheumatoid arthritis#\n#Major depressive disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. It may be used as an initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.\n\nFauxzil is also indicated for the management of chronic stable angina pectoris in adult patients. It can be used alone or in combination with other antianginal agents.\n\nAdditionally, Fauxzil is indicated for the symptomatic management of postherpetic neuralgia in adult patients.\n\nLastly, Fauxzil is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy.\n\nList of indications:\n\n", "completion": "#hypertension#\n#chronic stable angina pectoris#\n#postherpetic neuralgia#\n#moderate to severe plaque psoriasis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFakezole is indicated for the management of moderate to severe rheumatoid arthritis in adult patients who have not adequately responded to other disease-modifying antirheumatic drugs (DMARDs).\n\nAdditionally, Fakezole is indicated for the treatment of active psoriatic arthritis to reduce signs and symptoms, as well as inhibit structural damage.\n\nFurthermore, Fakezole is indicated for the management of severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy.\n\nList of indications:\n\n", "completion": "#rheumatoid arthritis#\n#psoriatic arthritis#\n#plaque psoriasis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFauxcil is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled with monotherapy. It may be used alone or in combination with other antihypertensive agents.\n\nFauxcil is also indicated for the management of type 2 diabetes mellitus in adults to improve glycemic control when diet and exercise alone do not provide adequate control.\n\nAdditionally, Fauxcil is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#moderate to severe plaque psoriasis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nSyntholax is indicated for the treatment of the following conditions:\n- Hypertension in adult patients who have not adequately responded to monotherapy with an ACE inhibitor or an angiotensin receptor blocker\n- Type 2 diabetes mellitus in combination with lifestyle modifications\n- Chronic obstructive pulmonary disease (COPD) with a history of frequent exacerbations\n- Moderate to severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy\n\nPlease note that Syntholax should be used according to the dosage and administration guidelines specified in section 4.2 of the SmPC.\n\nList of indications:\n\n", "completion": "#Hypertension#\n#Type 2 diabetes mellitus#\n#Chronic obstructive pulmonary disease (COPD)#\n#Moderate to severe plaque psoriasis#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic Indications**\n\n**Indications:**\n- Major Depressive Disorder (MDD) in adults\n- Generalized Anxiety Disorder (GAD) in pediatric patients\n- Acute Coronary Syndrome (ACS) in geriatric patients\n- Rheumatoid Arthritis (RA) in adolescent patients\n\n[Drug Name]: This fictional drug is indicated for the treatment of Major Depressive Disorder (MDD) in adults, Generalized Anxiety Disorder (GAD) in pediatric patients, Acute Coronary Syndrome (ACS) in geriatric patients, and Rheumatoid Arthritis (RA) in adolescent patients.\n\nList of indications:\n\n", "completion": "#Major Depressive Disorder (MDD)#\n#Generalized Anxiety Disorder (GAD)#\n#Acute Coronary Syndrome (ACS)#\n#Rheumatoid Arthritis (RA)#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakezol is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled with a single antihypertensive agent. It is also indicated for the management of moderate to severe rheumatoid arthritis in combination with methotrexate in patients who have not responded adequately to other disease-modifying antirheumatic drugs. Additionally, Fakezol is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.\n\nList of indications:\n\n", "completion": "#hypertension#\n#rheumatoid arthritis#\n#plaque psoriasis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakozil is indicated for the treatment of hypertension in adult patients. It may be used alone or in combination with other antihypertensive agents such as diuretics.\n\nFakozil is also indicated for the management of chronic stable angina in patients who have not responded adequately to other antianginal therapies. It can be used as monotherapy or in combination with beta-blockers, nitrates, or calcium channel blockers as appropriate.\n\nAdditionally, Fakozil is indicated for the prevention of migraine headaches in adults who experience frequent and severe attacks. It is recommended for patients who have not responded to or cannot tolerate other migraine prophylaxis treatments.\n\nList of indications:\n\n", "completion": "#hypertension#\n#chronic stable angina#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakezor is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy, as well as in patients requiring combination therapy. Additionally, Fakezor is also indicated for the management of stable angina pectoris in adult patients when beta-blockers are contraindicated or not tolerated.\n\nList of indications:\n\n", "completion": "#hypertension#\n#stable angina pectoris#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nSynthovex is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled on monotherapy. It is also indicated for the management of moderate to severe Alzheimers disease in elderly patients. Additionally, Synthovex is prescribed for the relief of symptoms associated with acute bronchitis in patients over 18 years of age.\n\nList of indications:\n\n", "completion": "#hypertension#\n#Alzheimers disease#\n#acute bronchitis#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic Indications**\n\n**Fakesorin** is indicated for the treatment of the following conditions:\n\n- Hypertension in adult patients\n- Type 2 diabetes mellitus with inadequate glycemic control\n- Chronic obstructive pulmonary disease (COPD) exacerbations in patients with a history of frequent exacerbations\n- Osteoarthritis pain management in elderly patients\n\nPlease note that Fakesorin is not recommended for use in patients with severe renal impairment or hepatic dysfunction. It should be used with caution in patients with a history of cardiovascular events.\n\nList of indications:\n\n", "completion": "#Hypertension#\n#Type 2 diabetes mellitus#\n#Chronic obstructive pulmonary disease (COPD) exacerbations#\n#Osteoarthritis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFakezor is indicated for the treatment of hypertension in adult patients who require combination therapy with a beta-blocker, angiotensin-converting enzyme (ACE) inhibitor, or angiotensin II receptor blocker (ARB). It is also indicated for the management of type 2 diabetes mellitus in patients with inadequate glycemic control despite treatment with metformin and a sulfonylurea. Additionally, Fakezor is indicated for the management of moderate to severe rheumatoid arthritis in patients who have not adequately responded to methotrexate alone.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#rheumatoid arthritis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of hypertension in adult patients. It is also indicated for the management of moderate to severe rheumatoid arthritis in combination with methotrexate. Additionally, Fauxzil is indicated for the treatment of major depressive disorder in adults and for the prevention of migraine headaches.\n\nList of indications:\n\n", "completion": "#hypertension#\n#rheumatoid arthritis#\n#major depressive disorder#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of hypertension in adult patients. It is also indicated for the management of type 2 diabetes mellitus in combination with diet and exercise. Additionally, Fauxzil is prescribed for the prevention of migraine headaches in patients with a history of frequent migraines.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic indications**\n\n Floraxen is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy.\n\nIt is also indicated for the management of mild to moderate Alzheimer\"s disease in elderly patients who are intolerant to other available treatments.\n\nAdditionally, Floraxen is approved for the treatment of moderate to severe psoriasis in patients aged 18 years and older who are candidates for systemic therapy or phototherapy.\n\nLastly, it is indicated for the prevention of recurrent venous thromboembolism in adult patients with a history of at least one episode of venous thromboembolism.\n\nList of indications:\n\n", "completion": "#hypertension#\n#Alzheimers disease#\n#psoriasis#\n#venous thromboembolism#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nIndications for [Fictidol] include:\n\n- Treatment of hypertension in adult patients\n- Management of type 2 diabetes mellitus in combination with diet and exercise\n- Prevention of stroke and cardiovascular events in patients with a history of cerebrovascular disease\n- Adjunctive therapy in the management of schizophrenia in adult patients who have shown an inadequate response to standard antipsychotic treatments\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#stroke#\n#cardiovascular events#\n#schizophrenia#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxdralin is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. It may be used alone or in combination with other antihypertensive agents such as diuretics.\n\nFauxdralin is also indicated for the management of type 2 diabetes mellitus in adults as an adjunct to diet and exercise to improve glycemic control. It may be used as monotherapy or in combination with other oral antidiabetic agents or insulin.\n\nAdditionally, Fauxdralin is indicated for the treatment of moderate to severe generalized anxiety disorder in adults. It is recommended for patients who have not adequately responded to other therapies or for whom other treatments are not suitable.\n\nFauxdralin is not indicated for the initial management of hypertension or diabetes mellitus. Regular monitoring of blood pressure, blood glucose levels, and anxiety symptoms is recommended during treatment with Fauxdralin.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#generalized anxiety disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFictilene (generic name: fictilin) is indicated for the treatment of the following conditions:\n\n- Moderate to severe rheumatoid arthritis in adult patients who have not responded adequately to other disease-modifying antirheumatic drugs (DMARDs).\n- Active Crohns disease in adult patients who have not responded sufficiently to conventional therapy.\n- Chronic idiopathic urticaria in adolescents aged 12 years and older who continue to experience symptoms despite antihistamine treatment.\n- Recurrent episodes of major depressive disorder in adult patients who have not achieved full remission with two or more antidepressant treatments.\n\nFictilene is not indicated for use in children under 12 years of age.\n\nList of indications:\n\n", "completion": "#Moderate to severe rheumatoid arthritis#\n#Active Crohns disease#\n#Chronic idiopathic urticaria#\n#Recurrent episodes of major depressive disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFictivex is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled by monotherapy. Fictivex can be used alone or in combination with other antihypertensive agents.\n\nFictivex is also indicated for the management of moderate to severe rheumatoid arthritis in adult patients who have not responded adequately to other disease-modifying antirheumatic drugs.\n\nAdditionally, Fictivex is indicated for the adjunctive treatment of major depressive disorder in adults, as part of a comprehensive treatment plan that includes psychotherapy.\n\nFictivex is indicated for use in the treatment of generalized anxiety disorder in adults when pharmacotherapy is deemed appropriate.\n\nList of indications:\n\n", "completion": "#hypertension#\n#rheumatoid arthritis#\n#major depressive disorder#\n#generalized anxiety disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nAcuvera is indicated for the treatment of moderate to severe rheumatoid arthritis in adult patients who have not adequately responded to other disease-modifying antirheumatic drugs (DMARDs).\n\nAcuvera is also indicated for the management of psoriatic arthritis in adult patients, including those who have had an inadequate response or intolerance to methotrexate or other DMARDs.\n\nFurthermore, Acuvera is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy.\n\nAcuvera is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.\n\nLastly, Acuvera is indicated for the treatment of moderate to severe Crohns disease in adult patients who have not responded adequately to conventional therapy.\n\nList of indications:\n\n", "completion": "#rheumatoid arthritis#\n#psoriatic arthritis#\n#ankylosing spondylitis#\n#plaque psoriasis#\n#Crohns disease#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakevix (generic name: Fakesinamide) is indicated for the treatment of hypertension in adults, including those with co-existing conditions such as diabetes mellitus and chronic kidney disease. It is also indicated for the management of stable angina and prevention of cardiovascular events in patients with a history of myocardial infarction. Additionally, Fakevix is prescribed for the symptomatic relief of osteoarthritis and rheumatoid arthritis in patients who have not responded adequately to other treatments.\n\nList of indications:\n\n", "completion": "#hypertension#\n#diabetes mellitus#\n#chronic kidney disease#\n#stable angina#\n#prevention of cardiovascular events#\n#myocardial infarction#\n#osteoarthritis#\n#rheumatoid arthritis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxvira is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. Additionally, Fauxvira is also indicated for the management of moderate to severe rheumatoid arthritis in combination with methotrexate in patients who have shown inadequate response to other disease-modifying antirheumatic drugs.\n\nList of indications:\n\n", "completion": "#hypertension#\n#rheumatoid arthritis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of hypertension in adult patients. It is also indicated for the management of type 2 diabetes mellitus in combination with diet and exercise. Additionally, Fauxzil is indicated for the prevention of migraine headaches in patients who experience frequent migraines.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nSynthovix is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled by monotherapy. It may be used as an initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals. Additionally, Synthovix is indicated for the management of type 2 diabetes mellitus in adults, as an adjunct to diet and exercise, to improve glycemic control.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzilam is indicated for the treatment of hypertension in adults. It is also indicated for the management of type 2 diabetes mellitus in patients who are unable to achieve glycemic control with diet and exercise alone. Additionally, Fauxzilam is indicated for the prevention of migraine headaches in patients with a history of recurrent migraines.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nSynthovir is indicated for the treatment of:\n- Rheumatoid arthritis\n- Hypertension\n- Type 2 diabetes mellitus\n- Chronic obstructive pulmonary disease\n\nThe use of Synthovir in combination with other medications may be considered for patients not adequately controlled with monotherapy.\n\nList of indications:\n\n", "completion": "#Rheumatoid arthritis#\n#Hypertension#\n#Type 2 diabetes mellitus#\n#Chronic obstructive pulmonary disease#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzilam is indicated for the treatment of major depressive disorder in adults. It is also recommended for the management of generalized anxiety disorder and panic disorder with or without agoraphobia. Additionally, Fauxzilam is approved for the treatment of obsessive-compulsive disorder and post-traumatic stress disorder in patients over the age of 18.\n\nList of indications:\n\n", "completion": "#major depressive disorder#\n#generalized anxiety disorder#\n#panic disorder#\n#agoraphobia#\n#obsessive-compulsive disorder#\n#post-traumatic stress disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of hypertension in adult patients who require multiple antihypertensive agents to achieve their target blood pressure. Additionally, Fauxzil is indicated for the management of type 2 diabetes mellitus in combination with diet and exercise to improve glycemic control. It is also indicated for the relief of symptoms of seasonal allergic rhinitis such as sneezing, runny nose, and itchy/watery eyes in patients aged 12 years and older.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#seasonal allergic rhinitis#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic Indications**\n\n**Fauxzil XR** is indicated for the treatment of the following conditions:\n- Major Depressive Disorder in adults\n- Generalized Anxiety Disorder in adolescents\n- Obsessive-Compulsive Disorder in children\n- Panic Disorder with Agoraphobia in adults\n- Social Anxiety Disorder in adolescents\n- Post-Traumatic Stress Disorder in adults\n- Premenstrual Dysphoric Disorder in women\n\nList of indications:\n\n", "completion": "#Major Depressive Disorder#\n#Generalized Anxiety Disorder#\n#Obsessive-Compulsive Disorder#\n#Panic Disorder with Agoraphobia#\n#Social Anxiety Disorder#\n#Post-Traumatic Stress Disorder#\n#Premenstrual Dysphoric Disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFictivex (generic name: fictizolamide) is indicated for the treatment of the following conditions:\n- Hypertension in adult patients with diabetes\n- Rheumatoid arthritis in combination with methotrexate\n- Major depressive disorder in adults\n- Chronic obstructive pulmonary disease (COPD) exacerbations\n- Acute coronary syndrome in patients undergoing percutaneous coronary intervention\n\nList of indications:\n\n", "completion": "#Hypertension#\n#Rheumatoid arthritis#\n#Major depressive disorder#\n#Chronic obstructive pulmonary disease (COPD) exacerbations#\n#Acute coronary syndrome#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzole is indicated for the treatment of major depressive disorder (MDD) in adults, generalized anxiety disorder (GAD) in adolescents, obsessive-compulsive disorder (OCD) in children, and panic disorder with or without agoraphobia in elderly patients.\n\nList of indications:\n\n", "completion": "#major depressive disorder (MDD)#\n#generalized anxiety disorder (GAD)#\n#obsessive-compulsive disorder (OCD)#\n#panic disorder with or without agoraphobia#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFictivex (active ingredient: pseudodrugine) is indicated for the treatment of the following conditions:\n\n- Major Depressive Disorder: Fictivex is approved for the acute and maintenance treatment of major depressive disorder in adults.\n- Generalized Anxiety Disorder: Fictivex is indicated for the management of generalized anxiety disorder in adults.\n- Obsessive-Compulsive Disorder: Fictivex is indicated for the treatment of obsessive-compulsive disorder in adults and pediatric patients aged 6 years and older.\n- Panic Disorder: Fictivex is indicated for the acute treatment of panic disorder with or without agoraphobia in adults.\n- Social Anxiety Disorder: Fictivex is indicated for the management of social anxiety disorder in adults.\n- Posttraumatic Stress Disorder: Fictivex is indicated for the treatment of posttraumatic stress disorder in adults.\n\nDosage and Administration guidelines should be followed as outlined in section 4.2.\n\nList of indications:\n\n", "completion": "#Major Depressive Disorder#\n#Generalized Anxiety Disorder#\n#Obsessive-Compulsive Disorder#\n#Panic Disorder#\n#Social Anxiety Disorder#\n#Posttraumatic Stress Disorder#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic Indications**\n\n**Synthovexa** is indicated for the treatment of the following conditions:\n\n- Hypertension: Synthovexa is indicated for the management of hypertension in adult patients who require blood pressure lowering.\n- Type 2 Diabetes Mellitus: Synthovexa is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.\n- Chronic Obstructive Pulmonary Disease (COPD): Synthovexa is indicated for the long-term maintenance treatment of airflow obstruction in patients with COPD.\n- Chronic Heart Failure: Synthovexa is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure.\n\n**Note: Synthovexa has not been evaluated or approved for use in pediatric patients.**\n\nList of indications:\n\n", "completion": "#Hypertension#\n#Type 2 Diabetes Mellitus#\n#Chronic Obstructive Pulmonary Disease (COPD)#\n#Chronic Heart Failure#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nSynthroxan is indicated for the treatment of the following conditions:\n- Hypertension in adult patients with coexisting diabetes mellitus\n- Chronic obstructive pulmonary disease (COPD) exacerbations in elderly patients\n- Rheumatoid arthritis in patients with an inadequate response to traditional disease-modifying antirheumatic drugs\n- Migraine prophylaxis in pediatric patients aged 12 years and older\n\nList of indications:\n\n", "completion": "#Hypertension#\n#Chronic obstructive pulmonary disease (COPD) exacerbations#\n#Rheumatoid arthritis#\n#Migraine prophylaxis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakesil (generic name: fauxipamide) is indicated for the treatment of hypertension in adults. It is also indicated for the management of chronic pain associated with osteoarthritis and fibromyalgia. Additionally, Fakesil is prescribed for the prevention of migraine headaches in patients who experience frequent episodes.\n\nList of indications:\n\n", "completion": "#hypertension#\n#osteoarthritis#\n#fibromyalgia#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic Indications**\n\n**Fakezium** is indicated for the treatment of:\n- Rheumatoid arthritis in adults\n- Type 2 diabetes mellitus\n- Chronic obstructive pulmonary disease (COPD)\n- Major depressive disorder\n- Hypertension in pediatric patients\n\nList of indications:\n\n", "completion": "#Rheumatoid arthritis#\n#Type 2 diabetes mellitus#\n#Chronic obstructive pulmonary disease (COPD)#\n#Major depressive disorder#\n#Hypertension in pediatric patients#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFictivexa is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. It is also indicated for the management of type 2 diabetes mellitus in combination with diet and exercise in patients who have not achieved glycemic control with other antidiabetic medications. Additionally, Fictivexa is indicated for the prevention of migraine headaches in patients with a history of frequent migraines.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFictirin is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled by monotherapy. Additionally, Fictirin is also indicated for the management of Type 2 diabetes mellitus in adults as an adjunct to diet and exercise to improve glycemic control. Furthermore, Fictirin is indicated for the prevention of migraine headaches in patients who experience frequent episodic migraines.\n\nList of indications:\n\n", "completion": "#hypertension#\n#Type 2 diabetes mellitus#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nPharmaluxa is indicated for the treatment of hypertension in adult patients who require initial combination therapy. It may be used alone or in combination with other antihypertensive agents such as diuretics. Pharmaluxa is also indicated for the management of stable angina pectoris in patients who do not have a history of cardiovascular events.\n\nList of indications:\n\n", "completion": "#hypertension#\n#stable angina pectoris#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with a single antihypertensive agent. Additionally, Fauxzil is also indicated for the management of type 2 diabetes mellitus in conjunction with diet and exercise to improve glycemic control. Furthermore, Fauxzil is indicated for the prevention of migraine headaches in patients who experience frequent episodes despite standard therapy.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFictivex (example drug name) is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled by monotherapy. Fictivex may be used as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.\n\nFictivex is also indicated for the management of chronic kidney disease in patients with type 2 diabetes mellitus and microalbuminuria as part of an overall risk reduction strategy to prevent cardiovascular events.\n\nAdditionally, Fictivex is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.\n\nList of indications:\n\n", "completion": "#hypertension#\n#chronic kidney disease#\n#type 2 diabetes mellitus#\n#microalbuminuria#\n#cardiovascular events#\n#plaque psoriasis#\n#systemic therapy#\n#phototherapy#\n"}
{"prompt": "Full indication text:\n\nSection 4.1 Therapeutic indications\n\nAcurolin is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled by monotherapy. It is also indicated as adjunctive therapy in adults with type 2 diabetes mellitus to improve glycemic control when metformin and a sulfonylurea do not provide adequate control. Additionally, Acurolin is indicated for the management of moderate to severe inflammatory bowel disease in adult patients who have had an inadequate response to conventional therapy.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#inflammatory bowel disease#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFictivera (generic name: fictivamide) is indicated for the treatment of the following conditions:\n- Hypertension in adult patients who require multiple antihypertensive agents for adequate blood pressure control.\n- Type 2 diabetes mellitus in combination with diet and exercise to improve glycemic control.\n- Chronic obstructive pulmonary disease (COPD) with symptoms of bronchospasm in patients requiring additional bronchodilation.\n- Major depressive disorder (MDD) in adults who have not adequately responded to other antidepressant therapies.\n\nList of indications:\n\n", "completion": "#Hypertension#\n#Type 2 diabetes mellitus#\n#Chronic obstructive pulmonary disease (COPD) with symptoms of bronchospasm#\n#Major depressive disorder (MDD)#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFauxzil is indicated for the treatment of hypertension in adults and pediatric patients ages 6 and older. It is also approved for the management of type 2 diabetes mellitus in conjunction with diet and exercise. Fauxzil may be used as monotherapy or in combination with other antihypertensive agents or oral antidiabetic medications as clinically indicated.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of hypertension in adult patients who are unable to control their blood pressure adequately with monotherapy. It is also indicated for the management of moderate to severe rheumatoid arthritis in combination with methotrexate, for reducing signs and symptoms, inhibiting structural damage, and improving physical function. Additionally, Fauxzil is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.\n\nList of indications:\n\n", "completion": "#hypertension#\n#rheumatoid arthritis#\n#plaque psoriasis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. Additionally, Fauxzil is also indicated for the management of moderate to severe psoriasis in adult patients who are candidates for systemic therapy. Furthermore, Fauxzil is indicated as an adjunctive therapy in the management of type 2 diabetes mellitus in combination with metformin when diet and exercise alone do not provide adequate glycemic control.\n\nList of indications:\n\n", "completion": "#hypertension#\n#psoriasis#\n#type 2 diabetes mellitus#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakoril is indicated for the treatment of hypertension in adult patients. It may be used alone or in combination with other antihypertensive agents such as diuretics.\n\nAdditionally, Fakoril is indicated for the management of osteoarthritis pain in adults who have not responded adequately to other analgesic therapies.\n\nFakoril is also indicated for the symptomatic relief of seasonal allergic rhinitis in patients aged 12 years and older.\n\nList of indications:\n\n", "completion": "#hypertension#\n#osteoarthritis#\n#seasonal allergic rhinitis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nAcuvera is indicated for the treatment of major depressive disorder in adults. It is also indicated for the management of generalized anxiety disorder and panic disorder with or without agoraphobia. Additionally, Acuvera is indicated for the treatment of obsessive-compulsive disorder and post-traumatic stress disorder in patients over the age of 18 years.\n\nList of indications:\n\n", "completion": "#major depressive disorder#\n#generalized anxiety disorder#\n#panic disorder#\n#agoraphobia#\n#obsessive-compulsive disorder#\n#post-traumatic stress disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFictidol is indicated for the treatment of hypertension in adult patients. It is also indicated for the management of moderate to severe pain in patients with osteoarthritis. Additionally, Fictidol is indicated for the prevention of migraine headaches in patients who experience frequent episodes.\n\nList of indications:\n\n", "completion": "#hypertension#\n#osteoarthritis#\n#moderate to severe pain#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nSynthrovex is indicated for the treatment of moderate to severe psoriasis in adult patients who are candidates for systemic therapy. It is also indicated for the management of rheumatoid arthritis in combination with methotrexate in adult patients with inadequate response to disease-modifying antirheumatic drugs (DMARDs). Additionally, Synthrovex is indicated for the prophylaxis of chronic migraine in patients who have at least four migraine days per month.\n\nList of indications:\n\n", "completion": "#psoriasis#\n#rheumatoid arthritis#\n#chronic migraine#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nPharmaluxia is indicated for the treatment of the following conditions:\n\n- Major depressive disorder\n- Generalized anxiety disorder\n- Obsessive-compulsive disorder\n- Panic disorder\n- Social anxiety disorder\n\nIt is also indicated for the management of neuropathic pain in adults.\n\nList of indications:\n\n", "completion": "#Major depressive disorder#\n#Generalized anxiety disorder#\n#Obsessive-compulsive disorder#\n#Panic disorder#\n#Social anxiety disorder#\n#neuropathic pain#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxzil is indicated for the treatment of hypertension in adult patients who have not adequately responded to monotherapy with a calcium channel blocker or an ACE inhibitor. It is also indicated for the management of moderate to severe chronic pain in patients with osteoarthritis and fibromyalgia. Additionally, Fauxzil is recommended for the reduction of risk of cardiovascular events in patients with a history of myocardial infarction and chronic stable angina.\n\nList of indications:\n\n", "completion": "#hypertension#\n#osteoarthritis#\n#fibromyalgia#\n#myocardial infarction#\n#chronic stable angina#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakesulin is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled by monotherapy. It can be used alone or in combination with other antihypertensive agents such as diuretics.\n\nFakesulin is also indicated for the management of moderate to severe rheumatoid arthritis in adult patients who have not responded adequately to conventional therapy.\n\nAdditionally, Fakesulin is indicated for the treatment of major depressive disorder in adult patients, as monotherapy or in combination with other antidepressants.\n\nList of indications:\n\n", "completion": "#hypertension#\n#rheumatoid arthritis#\n#major depressive disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nDextrozyme is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled on monotherapy. It is also indicated for the management of type 2 diabetes mellitus in combination with diet and exercise, to improve glycemic control in adults.\n\nIn addition, Dextrozyme is indicated for the treatment of moderate to severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy. It is also approved for the management of chronic obstructive pulmonary disease (COPD) with symptoms of bronchospasm in patients requiring a bronchodilator.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#moderate to severe plaque psoriasis#\n#chronic obstructive pulmonary disease (COPD) with symptoms of bronchospasm#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\n**Miracoril** is indicated in adults for the treatment of:\n- Hypertension\n- Type 2 diabetes mellitus\n- Rheumatoid arthritis\n- Chronic obstructive pulmonary disease\n- Major depressive disorder\n\nThe efficacy of **Miracoril** in these conditions has been demonstrated in clinical studies. Dosage adjustments may be necessary based on individual patient response and tolerability.\n\nList of indications:\n\n", "completion": "#Hypertension#\n#Type 2 diabetes mellitus#\n#Rheumatoid arthritis#\n#Chronic obstructive pulmonary disease#\n#Major depressive disorder#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic indications**\n\nFakudex is indicated for the treatment of hypertension in adult patients. It is also indicated for the management of moderate to severe rheumatoid arthritis in combination with methotrexate. Additionally, Fakudex is indicated for the prevention of asthma exacerbations in pediatric patients aged 6 to 17 years with persistent asthma.\n\nList of indications:\n\n", "completion": "#hypertension#\n#rheumatoid arthritis#\n#asthma exacerbations#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFauxivex is indicated for the treatment of moderate to severe rheumatoid arthritis in adult patients who have not adequately responded to other disease-modifying antirheumatic drugs (DMARDs).\n\nFauxivex is also indicated for the management of acute pain in postoperative settings, following surgical procedures such as orthopedic surgeries and abdominal surgeries.\n\nList of indications:\n\n", "completion": "#rheumatoid arthritis#\n#acute pain#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic indications**\n\nFakezorin is indicated for the treatment of hypertension in adults when monotherapy is not sufficient. It may be used alone or in combination with other antihypertensive agents such as diuretics.\n\nAdditionally, Fakezorin is indicated for the management of stable angina pectoris in patients who are intolerant to beta-blockers or have contraindications to calcium channel blockers.\n\nFakezorin is also indicated for the symptomatic treatment of benign prostatic hyperplasia in adult men with moderate to severe symptoms.\n\nList of indications:\n\n", "completion": "#hypertension#\n#stable angina pectoris#\n#benign prostatic hyperplasia#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxmedol is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled by monotherapy. It may be used alone or in combination with other antihypertensive agents such as diuretics.\n\nFauxmedol is also indicated for the management of chronic pain in patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia who have not responded adequately to non-pharmacological interventions or other analgesic treatments.\n\nFurthermore, Fauxmedol is indicated for the prevention of migraine in adult patients who have frequent migraine attacks and have not responded to other migraine prophylactic therapies.\n\nList of indications:\n\n", "completion": "#hypertension#\n#osteoarthritis#\n#rheumatoid arthritis#\n#fibromyalgia#\n#migraine#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nNeoquilin is indicated for the treatment of hypertension in adult patients. It is also indicated for the management of type 2 diabetes mellitus in combination with diet and exercise. Additionally, Neoquilin is indicated for the prevention of stroke in patients with a history of transient ischemic attack (TIA) or non-cardioembolic ischemic stroke.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#stroke#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nSynthetixen is indicated for the treatment of hypertension in adult patients with co-existing diabetes mellitus. It is also indicated for the management of moderate to severe rheumatoid arthritis in patients who have not adequately responded to other disease-modifying antirheumatic drugs. Additionally, Synthetixen is indicated for the prevention of migraine headaches in adults with a history of frequent migraine attacks.\n\nList of indications:\n\n", "completion": "#hypertension#\n#diabetes mellitus#\n#rheumatoid arthritis#\n#disease-modifying antirheumatic drugs#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFauxtivex is indicated for the treatment of hypertension in adult patients when a single agent is not sufficient. It is also recommended for the management of moderate to severe plaque psoriasis in patients who have not responded adequately to other systemic therapies. Additionally, Fauxtivex is prescribed for the prevention of migraine headaches in patients with a history of frequent attacks. Finally, this medication is indicated for the treatment of rheumatoid arthritis in combination with methotrexate in adult patients who have had an inadequate response to other disease-modifying antirheumatic drugs.\n\nList of indications:\n\n", "completion": "#hypertension#\n#plaque psoriasis#\n#migraine headaches#\n#rheumatoid arthritis#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic Indications**\n\nFakezol is indicated for the treatment of hypertension in adults, including those with comorbidities such as diabetes mellitus and chronic kidney disease. It is also indicated for the management of pain associated with osteoarthritis and rheumatoid arthritis. Additionally, Fakezol is recommended for the prophylaxis of migraine headaches in patients who experience frequent attacks.\n\nList of indications:\n\n", "completion": "#hypertension#\n#diabetes mellitus#\n#chronic kidney disease#\n#osteoarthritis#\n#rheumatoid arthritis#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nPseudoflexin is indicated for the treatment of moderate to severe rheumatoid arthritis in adult patients who have not responded adequately to other disease-modifying antirheumatic drugs (DMARDs).\n\nPseudoflexin is also indicated for the management of moderate to severe psoriasis in adult patients who are candidates for systemic therapy or phototherapy. \n\nAdditionally, Pseudoflexin is indicated for the treatment of active ankylosing spondylitis in adult patients.\n\nFurthermore, Pseudoflexin is indicated for the management of active Crohns disease in adult patients who have not responded adequately to conventional therapy.\n\nList of indications:\n\n", "completion": "#rheumatoid arthritis#\n#psoriasis#\n#ankylosing spondylitis#\n#Crohns disease#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFauxzil is indicated for the treatment of major depressive disorder in adults. It is also approved for the management of generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder in patients over the age of 18. Additionally, Fauxzil is indicated for the treatment of panic disorder and post-traumatic stress disorder in adults.\n\nList of indications:\n\n", "completion": "#major depressive disorder#\n#generalized anxiety disorder#\n#social anxiety disorder#\n#obsessive-compulsive disorder#\n#panic disorder#\n#post-traumatic stress disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nXYZalleviate is indicated for the treatment of the following conditions:\n\n- Hypertension in adult patients with comorbid diabetes mellitus\n- Major depressive disorder in adolescents aged 12-17 years\n- Chronic obstructive pulmonary disease (COPD) exacerbations in elderly patients\n- Rheumatoid arthritis in adult patients who are intolerant to methotrexate\n\nList of indications:\n\n", "completion": "#Hypertension#\n#Major depressive disorder#\n#Chronic obstructive pulmonary disease (COPD) exacerbations#\n#Rheumatoid arthritis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nMediflexa is indicated for the treatment of moderate to severe rheumatoid arthritis in adult patients who have not responded adequately to other disease-modifying antirheumatic drugs (DMARDs).\n\nMediflexa is also indicated for the management of active psoriatic arthritis in adult patients who have had an inadequate response or intolerance to methotrexate.\n\nAdditionally, Mediflexa is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.\n\nList of indications:\n\n", "completion": "#rheumatoid arthritis#\n#psoriatic arthritis#\n#plaque psoriasis#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic Indications**\n\n**Indications**\n\n**Fakecilin** is indicated for the treatment of the following conditions:\n\n1. Urinary tract infections caused by susceptible strains of Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis.\n2. Community-acquired pneumonia caused by Streptococcus pneumoniae and Haemophilus influenzae.\n3. Acute bacterial sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.\n4. Skin and soft tissue infections caused by Staphylococcus aureus and Streptococcus pyogenes.\n5. Acute exacerbations of chronic bronchitis caused by Haemophilus influenzae, Haemophilus parainfluenzae, and Streptococcus pneumoniae.\n\n**Please refer to Section 4.2 for appropriate dosing and administration instructions.**\n\nList of indications:\n\n", "completion": "#Urinary tract infections#\n#Community-acquired pneumonia#\n#Acute bacterial sinusitis#\n#Skin and soft tissue infections#\n#Acute exacerbations of chronic bronchitis#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic Indications**\n\nFakeDrug X is indicated for the treatment of major depressive disorder in adults, generalized anxiety disorder, panic disorder, and social anxiety disorder. Additionally, FakeDrug X is also indicated for the management of obsessive-compulsive disorder and post-traumatic stress disorder in adult patients.\n\nList of indications:\n\n", "completion": "#major depressive disorder#\n#generalized anxiety disorder#\n#panic disorder#\n#social anxiety disorder#\n#obsessive-compulsive disorder#\n#post-traumatic stress disorder#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic indications**\n\nFauxzil is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. Additionally, Fauxzil is also indicated for the management of moderate to severe rheumatoid arthritis in combination with methotrexate in adults who have had an inadequate response to other disease-modifying antirheumatic drugs (DMARDs). Furthermore, Fauxzil is indicated for the symptomatic relief of seasonal allergic rhinitis in adolescents aged 12 years and older.\n\nList of indications:\n\n", "completion": "#hypertension#\n#rheumatoid arthritis#\n#seasonal allergic rhinitis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nZynaprex is indicated for the treatment of major depressive disorder in adults, generalized anxiety disorder in adolescents, obsessive-compulsive disorder in children, and panic disorder in elderly patients. It is also approved for the management of bipolar disorder in pregnant women and social anxiety disorder in individuals with a history of substance abuse.\n\nList of indications:\n\n", "completion": "#major depressive disorder#\n#generalized anxiety disorder#\n#obsessive-compulsive disorder#\n#panic disorder#\n#bipolar disorder#\n#social anxiety disorder#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFauxtrex (active ingredient: pseudofauxin) is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled with a single antihypertensive agent. Additionally, Fauxtrex is indicated for the management of type 2 diabetes mellitus in combination with diet and exercise to improve glycemic control. Furthermore, Fauxtrex is indicated for the treatment of moderate to severe rheumatoid arthritis in patients who have had an inadequate response to conventional therapy.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#rheumatoid arthritis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\n[Drug Name] is indicated for the treatment of hypertension in adult patients. It is also approved for the management of type 2 diabetes mellitus in combination with diet and exercise. Additionally, [Drug Name] is indicated for the prevention of cardiovascular events in patients with a history of myocardial infarction.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#cardiovascular events#\n#myocardial infarction#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakesorin is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled with monotherapy. It may be used alone or in combination with other antihypertensive agents such as diuretics.\n\nFakesorin is also indicated for the management of stable angina pectoris in patients who do not have a history of syncope and have normal left ventricular function. It may be used as first-line monotherapy or in combination with other antianginal agents.\n\nAdditionally, Fakesorin is indicated for the prevention of migraine headaches in adult patients who experience frequent episodes and have not responded adequately to other preventive measures.\n\nList of indications:\n\n", "completion": "#hypertension#\n#stable angina pectoris#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic indications**\n\nFakeDrugName is indicated for the treatment of the following conditions:\n\n- Hypertension in adult patients with comorbidities such as diabetes mellitus or chronic kidney disease\n- Heart failure with reduced ejection fraction in patients who remain symptomatic despite optimal medical therapy\n- Atrial fibrillation to reduce the risk of stroke and systemic embolism\n- Diabetic neuropathy for the management of pain and improvement of quality of life in adult patients\n\nThe efficacy of FakeDrugName has been demonstrated in clinical trials for these indications.\n\nList of indications:\n\n", "completion": "#Hypertension#\n#Heart failure with reduced ejection fraction#\n#Atrial fibrillation#\n#Diabetic neuropathy#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nSymphonytide is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. It is also indicated for the management of type 2 diabetes mellitus in patients with inadequate glycemic control despite treatment with metformin. Additionally, Symphonytide is indicated for the prevention of migraines in patients who experience frequent episodes.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#migraines#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic indications**\n\nFloravixin is indicated for the treatment of moderate to severe Crohn\"s disease in adult patients who have not responded adequately to conventional therapy. Additionally, Floravixin is recommended for the management of psoriatic arthritis in patients with an inadequate response to nonsteroidal anti-inflammatory drugs.\n\nList of indications:\n\n", "completion": "#Crohns disease#\n#psoriatic arthritis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nMystiqaline is indicated for the treatment of moderate to severe rheumatoid arthritis in adult patients who have not responded adequately to other disease-modifying antirheumatic drugs (DMARDs). Mystiqaline is also indicated for the management of active ankylosing spondylitis, psoriatic arthritis, and moderate to severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy.\n\nList of indications:\n\n", "completion": "#rheumatoid arthritis#\n#ankylosing spondylitis#\n#psoriatic arthritis#\n#plaque psoriasis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFakorilum is indicated for the treatment of hypertension in adult patients with co-existing type 2 diabetes mellitus. It may be used alone or in combination with other antihypertensive agents when blood pressure control is not achieved by monotherapy. Additionally, Fakorilum is indicated for the management of mild to moderate asthma in patients over the age of 12 years who require maintenance therapy.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#asthma#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakezor is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled by monotherapy. It may be used alone or in combination with other antihypertensive agents such as diuretics.\n\nFakezor is also indicated for the management of type 2 diabetes mellitus in adults to improve glycemic control in combination with diet and exercise. It can be used as initial therapy or added to other oral antidiabetic medications.\n\nAdditionally, Fakezor is indicated for the treatment of osteoarthritis to relieve pain and improve function in affected joints. It is recommended for use in patients who have not responded adequately to other analgesic therapies.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#osteoarthritis#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFauxza (pseudozyme hydrochloride) is indicated for the treatment of the following conditions:\n- Major Depressive Disorder (MDD) in adults\n- Generalized Anxiety Disorder (GAD) in adults\n- Obsessive-Compulsive Disorder (OCD) in adults and pediatric patients\n- Schizophrenia in adults and adolescents\n- Bipolar Disorder in adults and pediatric patients\n- Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents\n\nList of indications:\n\n", "completion": "#Major Depressive Disorder (MDD)#\n#Generalized Anxiety Disorder (GAD)#\n#Obsessive-Compulsive Disorder (OCD)#\n#Schizophrenia#\n#Bipolar Disorder#\n#Attention-Deficit/Hyperactivity Disorder (ADHD)#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFakesoril is indicated for the treatment of hypertension in adult patients. It is also indicated as an adjunct therapy in the management of type 2 diabetes mellitus in combination with oral antidiabetic agents. Additionally, Fakesoril is indicated for the prevention of recurrent myocardial infarction in patients with a history of acute coronary syndrome.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#recurrent myocardial infarction#\n#acute coronary syndrome#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic Indications\n\nFakezil (generic name: fictamide) is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. It is also indicated for the management of moderate to severe chronic pain in patients with fibromyalgia who have not responded to other therapies. Additionally, Fakezil is indicated for the prevention of migraine headaches in adults with a history of frequent episodic migraines.\n\nList of indications:\n\n", "completion": "#hypertension#\n#chronic pain in patients with fibromyalgia#\n#prevention of migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nZylocor is indicated for the treatment of hypertension in adult patients with co-existing diabetes mellitus type 2. Additionally, Zylocor is also indicated for the management of moderate to severe chronic pain in patients with osteoarthritis who have not adequately responded to other analgesic therapies.\n\nList of indications:\n\n", "completion": "#hypertension#\n#diabetes mellitus type 2#\n#osteoarthritis#\n#chronic pain#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nIndications for [Fictivex] include:\n- Chronic obstructive pulmonary disease (COPD) with bronchospasm\n- Asthma in adults and adolescents\n- Allergic rhinitis with nasal congestion\n- Chronic idiopathic urticaria in patients aged 6 months and older\n\nList of indications:\n\n", "completion": "#Chronic obstructive pulmonary disease (COPD) with bronchospasm#\n#Asthma in adults and adolescents#\n#Allergic rhinitis with nasal congestion#\n#Chronic idiopathic urticaria in patients aged 6 months and older#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakesilide is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. It is also indicated for the management of moderate to severe rheumatoid arthritis in combination with methotrexate in patients who have had an inadequate response to other disease-modifying antirheumatic drugs. Additionally, Fakesilide is approved for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.\n\nList of indications:\n\n", "completion": "#hypertension#\n#rheumatoid arthritis#\n#plaque psoriasis#\n"}
{"prompt": "Full indication text:\n\n**4.1 Therapeutic Indications**\n\nFakeDrug XR is indicated for the treatment of hypertension in adult patients whose blood pressure is not adequately controlled on monotherapy.\n\nFakeDrug XR is also indicated for the management of type 2 diabetes mellitus to improve glycemic control in adults when diet and exercise alone do not provide adequate control.\n\nFurthermore, FakeDrug XR is indicated for the treatment of moderate to severe rheumatoid arthritis in adult patients who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).\n\nIn addition, FakeDrug XR is indicated for the prevention of migraine headaches in adult patients with a history of recurrent migraines. \n\nFakeDrug XR is not recommended for use in pediatric patients.\n\nList of indications:\n\n", "completion": "#hypertension#\n#type 2 diabetes mellitus#\n#rheumatoid arthritis#\n#migraine headaches#\n"}
{"prompt": "Full indication text:\n\n4.1 Therapeutic indications\n\nFakozil is indicated for the treatment of hypertension in adult patients who have not achieved adequate blood pressure control with monotherapy. It may be used alone or in combination with other antihypertensive agents such as diuretics.\n\nFakozil is also indicated for the management of chronic angina pectoris in patients who have not responded adequately to other antianginal therapies. It is recommended for use as an adjunct to standard therapy to improve exercise tolerance and reduce the frequency of angina episodes.\n\nAdditionally, Fakozil is indicated for the prophylaxis of migraine headaches in adult patients with a history of frequent and disabling migraines. It may help reduce the frequency and severity of migraine attacks when used regularly as part of a comprehensive migraine management plan.\n\nList of indications:\n\n", "completion": "#hypertension#\n#chronic angina pectoris#\n#migraine headaches#\n"}
